An 8 Week Study Looking At The Efficacy, Toleration And Safety Of SS-RBX For Stress Urinary Incontinence.
An 8-Week, Multi-Centre,Randomised Double-Blind, Placebo Controlled, Parallel Group Study To Evaluate The Efficacy,Toleration And Safety Of (+)- [S,S]- Reboxetine In The Treatment Of Stress Urinary Incontinence (SUI) In Women.
1 other identifier
interventional
402
2 countries
95
Brief Summary
A study designed to assess the efficacy, toleration and safety of SS-RBX for the treatment of stress urinary incontinence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Nov 2004
95 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2004
CompletedFirst Submitted
Initial submission to the registry
August 26, 2005
CompletedFirst Posted
Study publicly available on registry
August 30, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2006
CompletedApril 7, 2011
April 1, 2011
1.7 years
August 26, 2005
April 6, 2011
Conditions
Outcome Measures
Primary Outcomes (1)
Proof of concept study to assess the efficacy, tolerability and safety of SS-RBX vs. placebo in the treatment of SUI.
Secondary Outcomes (1)
To evaluate whether an upward dose adjustment affects the tolerability of SS-RBX.
Interventions
Eligibility Criteria
You may qualify if:
- Clinically significant stress urinary incontinence
You may not qualify if:
- History or evidence of any relevant confounding urological or neurological disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Pfizerlead
Study Sites (95)
Pfizer Investigational Site
Anchorage, Alaska, 99508, United States
Pfizer Investigational Site
Sun City, Arizona, 85351, United States
Pfizer Investigational Site
Tucson, Arizona, 85712-5803, United States
Pfizer Investigational Site
Tucson, Arizona, 85712, United States
Pfizer Investigational Site
Little Rock, Arkansas, 72205, United States
Pfizer Investigational Site
Atherton, California, 94027, United States
Pfizer Investigational Site
Carmichael, California, 95608, United States
Pfizer Investigational Site
Laguna Woods, California, 92653, United States
Pfizer Investigational Site
Murrieta, California, 92562, United States
Pfizer Investigational Site
Newport Beach, California, 92660, United States
Pfizer Investigational Site
Sacramento, California, 95825, United States
Pfizer Investigational Site
San Diego, California, 92103, United States
Pfizer Investigational Site
Tarzana, California, 91356, United States
Pfizer Investigational Site
Temecula, California, 92591, United States
Pfizer Investigational Site
Torrance, California, 90505, United States
Pfizer Investigational Site
Vista, California, 92084, United States
Pfizer Investigational Site
Aurora, Colorado, 80012, United States
Pfizer Investigational Site
Denver, Colorado, 80210, United States
Pfizer Investigational Site
Denver, Colorado, 80220, United States
Pfizer Investigational Site
Wheat Ridge, Colorado, 80033, United States
Pfizer Investigational Site
New London, Connecticut, 06320, United States
Pfizer Investigational Site
Waterbury, Connecticut, 06708, United States
Pfizer Investigational Site
Aventura, Florida, 33180, United States
Pfizer Investigational Site
New Port Richey, Florida, 34652, United States
Pfizer Investigational Site
Panama City, Florida, 32405, United States
Pfizer Investigational Site
Panama City, Florida, 32407, United States
Pfizer Investigational Site
Pembroke Pines, Florida, 33028, United States
Pfizer Investigational Site
Port Richey, Florida, 34668, United States
Pfizer Investigational Site
West Palm Beach, Florida, 33407, United States
Pfizer Investigational Site
Alpharetta, Georgia, 30005, United States
Pfizer Investigational Site
Coeur d'Alene, Idaho, 83814, United States
Pfizer Investigational Site
Arlington Heights, Illinois, 60004, United States
Pfizer Investigational Site
Chicago, Illinois, 60616, United States
Pfizer Investigational Site
Melrose Park, Illinois, 60160, United States
Pfizer Investigational Site
Greenwood, Indiana, 46143, United States
Pfizer Investigational Site
Indianapolis, Indiana, 46202, United States
Pfizer Investigational Site
Des Moines, Iowa, 50309, United States
Pfizer Investigational Site
Louisville, Kentucky, 40291, United States
Pfizer Investigational Site
Shreveport, Louisiana, 71106, United States
Pfizer Investigational Site
Greenbelt, Maryland, 20770, United States
Pfizer Investigational Site
Watertown, Massachusetts, 02472, United States
Pfizer Investigational Site
Jackson, Mississippi, 39202, United States
Pfizer Investigational Site
Jackson, Mississippi, 39216, United States
Pfizer Investigational Site
Liberty, Missouri, 64068, United States
Pfizer Investigational Site
North Kansas City, Missouri, 64116, United States
Pfizer Investigational Site
Omaha, Nebraska, 68114, United States
Pfizer Investigational Site
Henderson, Nevada, 89014, United States
Pfizer Investigational Site
Edison, New Jersey, 08837, United States
Pfizer Investigational Site
West Orange, New Jersey, 07052, United States
Pfizer Investigational Site
Albuquerque, New Mexico, 87108, United States
Pfizer Investigational Site
Albany, New York, 12208, United States
Pfizer Investigational Site
Garden City, New York, 11530-1630, United States
Pfizer Investigational Site
Garden City, New York, 11530, United States
Pfizer Investigational Site
Mineola, New York, 11501, United States
Pfizer Investigational Site
Poughkeepsie, New York, 12601, United States
Pfizer Investigational Site
Burlington, North Carolina, 27215, United States
Pfizer Investigational Site
Charlotte, North Carolina, 28204, United States
Pfizer Investigational Site
Concord, North Carolina, 28025, United States
Pfizer Investigational Site
Fayetteville, North Carolina, 28304, United States
Pfizer Investigational Site
Winston-Salem, North Carolina, 27103, United States
Pfizer Investigational Site
Cincinnati, Ohio, 45212, United States
Pfizer Investigational Site
Bethany, Oklahoma, 73008, United States
Pfizer Investigational Site
Eugene, Oregon, 97401-2676, United States
Pfizer Investigational Site
Eugene, Oregon, 97401, United States
Pfizer Investigational Site
Medford, Oregon, 97504, United States
Pfizer Investigational Site
Portland, Oregon, 97239, United States
Pfizer Investigational Site
Colmar, Pennsylvania, 18915, United States
Pfizer Investigational Site
Lancaster, Pennsylvania, 17604, United States
Pfizer Investigational Site
Philadelphia, Pennsylvania, 19114, United States
Pfizer Investigational Site
Pittsburgh, Pennsylvania, 15213, United States
Pfizer Investigational Site
Sellersville, Pennsylvania, 18960, United States
Pfizer Investigational Site
Sewickley, Pennsylvania, 15143, United States
Pfizer Investigational Site
Providence, Rhode Island, 02904, United States
Pfizer Investigational Site
Charleston, South Carolina, 29425, United States
Pfizer Investigational Site
Columbia, South Carolina, 29201, United States
Pfizer Investigational Site
Greer, South Carolina, 29651, United States
Pfizer Investigational Site
Myrtle Beach, South Carolina, 29572, United States
Pfizer Investigational Site
Knoxville, Tennessee, 37920-1522, United States
Pfizer Investigational Site
Knoxville, Tennessee, 37920, United States
Pfizer Investigational Site
Corpus Christi, Texas, 78414, United States
Pfizer Investigational Site
Corsicana, Texas, 75110, United States
Pfizer Investigational Site
Houston, Texas, 77024, United States
Pfizer Investigational Site
San Antonio, Texas, 78229, United States
Pfizer Investigational Site
Salt Lake City, Utah, 84132, United States
Pfizer Investigational Site
Sandy City, Utah, 84070, United States
Pfizer Investigational Site
Sandy City, Utah, 84094, United States
Pfizer Investigational Site
West Jordan, Utah, 84088, United States
Pfizer Investigational Site
Virginia Beach, Virginia, 23454, United States
Pfizer Investigational Site
Seattle, Washington, 98104, United States
Pfizer Investigational Site
Surrey, British Columbia, V3V-1N1, Canada
Pfizer Investigational Site
Victoria, British Columbia, V8T5G1, Canada
Pfizer Investigational Site
Kitchener, Ontario, N2M 5N4, Canada
Pfizer Investigational Site
Oakville, Ontario, L6H 3P1, Canada
Pfizer Investigational Site
Montreal, Quebec, H3S 1Z1, Canada
Pfizer Investigational Site
Pointe-Claire, Quebec, H9R 4S3, Canada
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Pfizer CT.gov Call Center
Pfizer
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
August 26, 2005
First Posted
August 30, 2005
Study Start
November 1, 2004
Primary Completion
August 1, 2006
Study Completion
August 1, 2006
Last Updated
April 7, 2011
Record last verified: 2011-04